Oligonucleotides as transcription factor decoys

Yoon S. Cho-Chung, Yun Gyu Park, Youl Nam Lee

Research output: Contribution to journalReview article

47 Citations (Scopus)

Abstract

Cellular and molecular research has been focused to develop a means to regulate gene expression in an effort to treat and cure a variety of diseases and abnormal physiological conditions. A successful oligonucleotide-based approach has been the use of synthetic oligonucleotides containing an enhancer element that can penetrate cells, bind sequence-specific DNA- binding proteins and interfere with transcription in vivo. This review describes such decoy oligonucleotides that exhibit high affinity for a target transcription factor and successfully interfere with transcription in vivo. Evidence presented here shows that the decoy oligonucleotide technology offers great promise as a tool for defining cellular regulatory processes and for treating cancer, viral diseases and other pathological conditions.

Original languageEnglish
Pages (from-to)386-392
Number of pages7
JournalCurrent Opinion in Molecular Therapeutics
Volume1
Issue number3
Publication statusPublished - 1999 Jun 1
Externally publishedYes

Fingerprint

Oligonucleotides
Transcription Factors
DNA-Binding Proteins
Virus Diseases
Technology
Gene Expression
Research
Neoplasms

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Oligonucleotides as transcription factor decoys. / Cho-Chung, Yoon S.; Park, Yun Gyu; Lee, Youl Nam.

In: Current Opinion in Molecular Therapeutics, Vol. 1, No. 3, 01.06.1999, p. 386-392.

Research output: Contribution to journalReview article

Cho-Chung, Yoon S. ; Park, Yun Gyu ; Lee, Youl Nam. / Oligonucleotides as transcription factor decoys. In: Current Opinion in Molecular Therapeutics. 1999 ; Vol. 1, No. 3. pp. 386-392.
@article{26c8605a4979449b9dcdd1868290ebd1,
title = "Oligonucleotides as transcription factor decoys",
abstract = "Cellular and molecular research has been focused to develop a means to regulate gene expression in an effort to treat and cure a variety of diseases and abnormal physiological conditions. A successful oligonucleotide-based approach has been the use of synthetic oligonucleotides containing an enhancer element that can penetrate cells, bind sequence-specific DNA- binding proteins and interfere with transcription in vivo. This review describes such decoy oligonucleotides that exhibit high affinity for a target transcription factor and successfully interfere with transcription in vivo. Evidence presented here shows that the decoy oligonucleotide technology offers great promise as a tool for defining cellular regulatory processes and for treating cancer, viral diseases and other pathological conditions.",
author = "Cho-Chung, {Yoon S.} and Park, {Yun Gyu} and Lee, {Youl Nam}",
year = "1999",
month = "6",
day = "1",
language = "English",
volume = "1",
pages = "386--392",
journal = "Current Opinion in Molecular Therapeutics",
issn = "1464-8431",
publisher = "Current Drugs Ltd.",
number = "3",

}

TY - JOUR

T1 - Oligonucleotides as transcription factor decoys

AU - Cho-Chung, Yoon S.

AU - Park, Yun Gyu

AU - Lee, Youl Nam

PY - 1999/6/1

Y1 - 1999/6/1

N2 - Cellular and molecular research has been focused to develop a means to regulate gene expression in an effort to treat and cure a variety of diseases and abnormal physiological conditions. A successful oligonucleotide-based approach has been the use of synthetic oligonucleotides containing an enhancer element that can penetrate cells, bind sequence-specific DNA- binding proteins and interfere with transcription in vivo. This review describes such decoy oligonucleotides that exhibit high affinity for a target transcription factor and successfully interfere with transcription in vivo. Evidence presented here shows that the decoy oligonucleotide technology offers great promise as a tool for defining cellular regulatory processes and for treating cancer, viral diseases and other pathological conditions.

AB - Cellular and molecular research has been focused to develop a means to regulate gene expression in an effort to treat and cure a variety of diseases and abnormal physiological conditions. A successful oligonucleotide-based approach has been the use of synthetic oligonucleotides containing an enhancer element that can penetrate cells, bind sequence-specific DNA- binding proteins and interfere with transcription in vivo. This review describes such decoy oligonucleotides that exhibit high affinity for a target transcription factor and successfully interfere with transcription in vivo. Evidence presented here shows that the decoy oligonucleotide technology offers great promise as a tool for defining cellular regulatory processes and for treating cancer, viral diseases and other pathological conditions.

UR - http://www.scopus.com/inward/record.url?scp=2442756427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442756427&partnerID=8YFLogxK

M3 - Review article

VL - 1

SP - 386

EP - 392

JO - Current Opinion in Molecular Therapeutics

JF - Current Opinion in Molecular Therapeutics

SN - 1464-8431

IS - 3

ER -